New Mouse Study Evaluates Obesity and Diabetes Treatment That Enhances GLP-1 Benefits
Researchers at the University of California, Berkeley, have evaluated a novel metabolic compound called TOFA in murine models, demonstrating a potential alternative approach to obesity and diabetes treatment. Published in … Read More